Orthobiologics

BONESUPPORT enrolled the first patient in the pivotal IDE trial of CERAMENT G in the surgical repair of open diaphyseal...

Interim study results indicate that patients receiving Rotation Medical’s Bioinductive Implant to treat rotator cuff disease reported statistically significant improvement...

CURASAN entered the U.S. market with the first U.S. implantation of CERASORB® Ortho Foam bone graft....

Carmell Therapeutics will launch a Phase III clinical study for Bone Healing Accelerant, its first Plasma-based Bioactive Material product/indication, designed to treat fractures....

Histogenics successfully completed consultations with Japan’s PMDA regarding the regulatory path for NeoCart® autologous cell therapy for the treatment of knee cartilage...

TheraCell was issued U.S. Patent No. 9,636,436, "Compositions of and Methods for Cancellous Bone Matrix," addressing its ECS™ enhanced cancellous demineralized...

SpinalCyte was issued Australian Patent No. 2013299505, “Generation of Cartilage Ex Vivo from Fibroblasts.”...

CellRight Technologies launched Matrix OI® Cortical Fibers, the latest in vivo verified osteoinductive matrix in its portfolio of regenerative human-derived...

Orthocell received a new patent in Singapore titled "Method for Producing a Collagen Membrane and Uses Thereof," relative to the CelGro®...

Six-month results from Phase I/II study indicate that RepliCel’s RCT-01 fibroblasts demonstrated product safety and clinical potential for tendon regeneration...